Approval · Notice of Compliance 20466 · 2018
ORGARAN: Notice of Compliance 20466
Issued February 9, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20466
- Date
- February 9, 2018
- Company
- Aspen Pharmacare Canada Inc.Oakville, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification number
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ORGARAN | 02129043 | Marketed |
Medicinal ingredients
- DANAPAROID SODIUM 1,250 UNIT per ML